Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
VE ›
VERRUNIX
Trademark search for:
VERRUNIX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-10-11 — Application filed
2018-10-15 — Application filed
2018-10-22 — Application filed
2019-01-22 — Assigned to examiner
2019-01-25 — Suspension letter written
2019-01-25 — Letter of suspension e-mailed
2019-01-25 — Notification of letter of suspension e-mailed
2019-08-09 — Suspension inquiry written
2019-08-09 — Inquiry to suspension e-mailed
2019-08-09 — Notification of inquiry as to suspension e-mailed
2020-01-31 — Teas response to suspension inquiry received
2020-02-04 — Assigned to lie
2020-02-05 — Correspondence received in law office
2020-02-05 — Teas/email correspondence entered
2020-02-06 — Suspension letter written
2020-02-06 — Letter of suspension e-mailed
2020-02-06 — Notification of letter of suspension e-mailed
2020-08-07 — Suspension inquiry written
2020-08-07 — Inquiry to suspension e-mailed
2020-08-07 — Notification of inquiry as to suspension e-mailed
2021-02-04 — Teas response to suspension inquiry received
2021-02-08 — Correspondence received in law office
2021-02-08 — Teas/email correspondence entered
2021-02-11 — Teas revoke/app/change addr of atty/dom rep received
2021-02-11 — Attorney/dom.rep.revoked and/or appointed
2021-02-11 — Teas change of correspondence received
2021-02-12 — Suspension letter written
2021-02-12 — Letter of suspension e-mailed
2021-02-12 — Notification of letter of suspension e-mailed
2021-08-17 — Suspension inquiry written
2021-08-17 — Inquiry to suspension e-mailed
2021-08-17 — Notification of inquiry as to suspension e-mailed
2022-02-16 — Teas response to suspension inquiry received
2022-02-23 — Assigned to lie
2022-02-25 — Correspondence received in law office
2022-02-25 — Teas/email correspondence entered
2022-03-02 — Approved for pub - principal register
2022-03-04 — On hold - electronic record review required
2022-03-08 — Electronic record review complete
2022-03-23 — Notification of notice of publication e-mailed
2022-04-12 — Published for opposition
2022-04-12 — Official gazette publication confirmation e-mailed
2022-06-07 — Noa e-mailed - sou required from applicant
2022-11-17 — Sou teas extension received
2022-11-17 — Sou extension 1 filed
2022-11-17 — Sou extension 1 granted
2022-11-19 — Notice of approval of extension request e-mailed
2023-07-10 — Application abandoned
2023-07-10 — Application abandoned
2023-07-10 — Final status recorded
Owner Information
Dermphi Therapeutics Inc.
Dermphi Therapeutics Inc.
Correspondent
B. Anna McCoy MCCOY RUSSELL LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
